XML 35 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Other Assets (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Dec. 19, 2017
Dec. 31, 2015
Dec. 31, 2017
Jun. 30, 2018
Jun. 30, 2017
Sep. 12, 2017
Mar. 23, 2016
Settlement loss       $ 62,425    
Intangible assets related to licenses       415,163 528,583    
Accumulated amortization       292,072 $ 243,408    
September 2018 [Member]              
Payments to acquire license rights       21,250      
EcoGen's Preferred Stock [Member]              
Percentage of ownership     100.00%        
Amount of owned by pharma     $ 635,000        
Share Transfer Agreement [Member] | EcoGen Preferred Stock [Member]              
Consideration transferred amount $ 300,000            
Other consideration in exchange approximately $ 370,000            
License Agreement [Member] | September 2018 [Member]              
Payments to acquire license rights       25,000      
Beechwood Properties, LLC [Member]              
Number of units acquired   280,000          
Percentage of membership interest acquired   2.00%          
Consideration transferred amount   $ 625,000          
Number of shares issued upon acquisition   625          
EcoGen Europe Limited ("EcoGen") [Member]              
Percentage of ownership             25.00%
EcoGen Europe Limited ("EcoGen") [Member] | Share Transfer Agreement [Member]              
Increased percentage of ownership 100.00%         75.00%  
EcoGen Europe Limited ("EcoGen") [Member] | Share Transfer Agreement [Member] | March 2016 investment [Member]              
Percentage of ownership 25.00%            
Scarlett Pharma Ltd ("Scarlett") [Member] | Share Transfer Agreement [Member]              
Additional number of shares surrendered 10,000,000            
EcoGen [Member]              
Intangible assets related to licenses       371,894      
Accumulated amortization       $ 331,894      
Intangible assets, useful life       20 years